CCL2 and mesothelioma: Also, in xenograft tumor models of mesothelioma and neuroblastoma, the genetic introduction of CCR2 in T cells resulted in increased T cell infiltration in tumors secreting CCL2 and was associated with significantly increased anti-tumor activity [21].